QWO
- Product code
- QWO
- Device name
- Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease.
- Device class
- Class 2
- 21 CFR
- 21 CFR 892.2085
- Medical specialty
- Radiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 4
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 4 (all years; only the last 3 years are listed here)
FDA classification definition
Radiology software for referral of findings related to fibrotic lung disease is a prescription image processing device that analyzes computed tomography images to suggest the presence of disease or of an imaging finding suggestive of disease. The output of this device is intended to be used as adjunctive information as part of a referral pathway in the overall diagnostic assessment process.
510(k) clearances, last 3 years (4)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K252041 | 2025-11-07 | Imvaria, Inc. | Fibresolve (with PCCP) | |
| K241891 | 2025-01-10 | Imvaria, Inc. | ScreenDx | |
| K242467 | 2024-12-19 | Imbio, Inc. | IQ-UIP | |
| DEN220040 | 2024-01-12 | Imvaria, Inc. | Fibresolve | — |
Official FDA classification page: QWO
Classification and pathway per current FDA publications. Data from openFDA (CC0).